| Nancy C Muller, MD | |
|
300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301-2844 | |
| (636) 947-5420 | |
| (636) 947-5257 |
| Full Name | Nancy C Muller |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 29 Years |
| Location | 300 1st Capitol Dr, Saint Charles, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770565525 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | 2002009365 (Missouri) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2002009365 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Alton Memorial Hospital | Alton, IL | Hospital |
| Ste Genevieve County Memorial Hospital | Sainte genevieve, MO | Hospital |
| Sparta Community Hospital | Sparta, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Analytical Pathology Services Ltd | 6800825480 | 6 |
| Analytical Pathology Services Ltd | 6800825480 | 6 |
News Archive
When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind.
Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.
City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrating that CEM-101 (solithromycin) is active against antibiotic-resistant strains of N. gonorrhoeae.
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events.
› Verified 1 days ago
| Entity Name | Analytical Pathology Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558343673 PECOS PAC ID: 6800825480 Enrollment ID: O20050804000977 |
News Archive
When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind.
Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.
City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrating that CEM-101 (solithromycin) is active against antibiotic-resistant strains of N. gonorrhoeae.
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events.
› Verified 1 days ago
| Entity Name | Allegiant Pathologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639151442 PECOS PAC ID: 4183727993 Enrollment ID: O20070316000015 |
News Archive
When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind.
Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.
City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrating that CEM-101 (solithromycin) is active against antibiotic-resistant strains of N. gonorrhoeae.
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy C Muller, MD Po Box 144333, Orlando, FL 32814-4333 Ph: (407) 422-9831 | Nancy C Muller, MD 300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301-2844 Ph: (636) 947-5420 |
News Archive
When a patient is diagnosed with eczema, the diagnosis of another medical condition may not be far behind.
Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.
City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrating that CEM-101 (solithromycin) is active against antibiotic-resistant strains of N. gonorrhoeae.
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events.
› Verified 1 days ago
Marshall E. Poger, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301 Phone: 636-947-5420 Fax: 636-947-5257 | |
Joseph A. Lombardo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301 Phone: 636-947-5420 Fax: 636-947-5257 | |
David K. Hopson, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301 Phone: 636-947-5420 Fax: 636-947-5257 | |
Elizabeth T. Mckinley, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Dept. Of Pathology, Saint Charles, MO 63301 Phone: 636-947-5420 Fax: 636-947-5257 |